<DOC>
	<DOCNO>NCT02517580</DOCNO>
	<brief_summary>This study single arm , single center clinical trial aim evaluate effect 8 week vitamin K2 replacement ( 360 mcg/day ) progression arterial stiffness stable renal transplant patient .</brief_summary>
	<brief_title>Vitamin K2 Supplementation Arterial Stiffness Renal Transplant Population ( The KING Trial )</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<criteria>Functional renal graft Stable renal function least 3 month prior enrollment History thrombotic event Diagnosed coagulopathy Cardiovascular event past month prior enrollment Current plan pregnancy Lactation Soy allergy Concomitant recent ( past 6 month ) use supplement contain vitamin K Warfarin treatment Known intestinal malabsorption hypomotility syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>